Publications found:
61,464
Sort by:
Gonorrhea R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF GONORRHEA PIPELINE REPORT INCLUDES Panorama of Gonorrhea pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Gorlin Syndrome (Basal Cell Nevus Syndrome) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF GORLIN SYNDROME (BASAL CELL NEVUS SYNDROME) PIPELINE REPORT INCLUDES Panorama of Gorlin Syndrome (Basal Cell Nevus Syndrome) pipeline markets including statistics on therapeutic drugs and companies involved Gorlin Syndrome (Basal Cell Nevus Syndrome) Pipeline candidates across ...
August 2018
30 pages
Gouty Arthritis (Gout) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GOUTY ARTHRITIS (GOUT) PIPELINE REPORT INCLUDES Panorama of Gouty Arthritis (Gout) pipeline markets including statistics on therapeutic drugs and companies involved Gouty Arthritis (Gout) Pipeline candidates across various development ...
August 2018
80 pages
Grass Pollen Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GRASS POLLEN ALLERGY PIPELINE REPORT INCLUDES Panorama of Grass Pollen Allergy pipeline markets including statistics on therapeutic drugs and companies involved Grass Pollen Allergy Pipeline candidates across various development ...
August 2018
50 pages
Graves Diseases R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GRAVES DISEASES PIPELINE REPORT INCLUDES Panorama of Graves Diseases pipeline markets including statistics on therapeutic drugs and companies involved Graves Diseases Pipeline candidates across various development ...
August 2018
30 pages
Graves' Ophthalmopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GRAVES' OPHTHALMOPATHY PIPELINE REPORT INCLUDES Panorama of Graves' Ophthalmopathy pipeline markets including statistics on therapeutic drugs and companies involved Graves' Ophthalmopathy Pipeline candidates across various development ...
August 2018
30 pages
Guillain Barre Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF GUILLAIN BARRE SYNDROME PIPELINE REPORT INCLUDES Panorama of Guillain Barre Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Guillain Barre Syndrome Pipeline candidates across various development ...
August 2018
40 pages
Haemophilus influenzae Type B Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF HAEMOPHILUS INFLUENZAE TYPE B INFECTIONS PIPELINE REPORT INCLUDES Panorama of Haemophilus influenzae Type B Infections pipeline markets including statistics on therapeutic drugs and companies involved Haemophilus influenzae Type B Infections Pipeline candidates across ...
August 2018
50 pages
Hairy Cell Leukemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HAIRY CELL LEUKEMIA PIPELINE REPORT INCLUDES Panorama of Hairy Cell Leukemia pipeline markets including statistics on therapeutic drugs and companies involved Hairy Cell Leukemia Pipeline candidates across various development ...
August 2018
70 pages
Heart Transplant Rejection R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HEART TRANSPLANT REJECTION PIPELINE REPORT INCLUDES Panorama of Heart Transplant Rejection pipeline markets including statistics on therapeutic drugs and companies involved Heart Transplant Rejection Pipeline candidates across various development ...
August 2018
30 pages
Heavy Metal Poisoning R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HEAVY METAL POISONING PIPELINE REPORT INCLUDES Panorama of Heavy Metal Poisoning pipeline markets including statistics on therapeutic drugs and companies involved Heavy Metal Poisoning Pipeline candidates across various development ...
August 2018
30 pages
Helicobacter pylori Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HELICOBACTER PYLORI INFECTIONS PIPELINE REPORT INCLUDES Panorama of Helicobacter pylori Infections pipeline markets including statistics on therapeutic drugs and companies involved Helicobacter pylori Infections Pipeline candidates across various development ...
August 2018
60 pages
Hematopoietic Stem Cell Transplantation (HSCT) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) PIPELINE REPORT INCLUDES Panorama of Hematopoietic Stem Cell Transplantation (HSCT) pipeline markets including statistics on therapeutic drugs and companies involved Hematopoietic Stem Cell Transplantation (HSCT) Pipeline candidates across ...
August 2018
70 pages
Hemochromatosis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HEMOCHROMATOSIS PIPELINE REPORT INCLUDES Panorama of Hemochromatosis pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Hemophilia A R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... VPA Research with comprehensive information of Hemophilia A pipeline products. The Hemophilia A pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEMOPHILIA A PIPELINE REPORT INCLUDES Panorama of Hemophilia A pipeline markets including statistics on therapeutic drugs and ...
August 2018
150 pages
Hemophilia B R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... VPA Research with comprehensive information of Hemophilia B pipeline products. The Hemophilia B pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEMOPHILIA B PIPELINE REPORT INCLUDES Panorama of Hemophilia B pipeline markets including statistics on therapeutic drugs and ...
August 2018
100 pages
Hemorrhage R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HEMORRHAGE PIPELINE REPORT INCLUDES Panorama of Hemorrhage pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Hepatic Colorectal Metastasis R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... comprehensive information of HepaticColorectal Metastasis pipeline products. The HepaticColorectal Metastasis pipeline guide presents complete ... use format. SCOPE OF HEPATIC%LI%COLORECTAL METASTASIS PIPELINE REPORT INCLUDES Panorama of HepaticColorectal Metastasis pipeline markets including statistics on ...
August 2018
30 pages
Hepatic Encephalopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HEPATIC ENCEPHALOPATHY PIPELINE REPORT INCLUDES Panorama of Hepatic Encephalopathy pipeline markets including statistics on therapeutic drugs and companies involved Hepatic Encephalopathy Pipeline candidates across various development ...
August 2018
50 pages
Hepatic Insufficiency R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HEPATIC INSUFFICIENCY PIPELINE REPORT INCLUDES Panorama of Hepatic Insufficiency pipeline markets including statistics on therapeutic drugs and companies involved Hepatic Insufficiency Pipeline candidates across various development ...
August 2018
60 pages
Hepatitis A R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... from VPA Research with comprehensive information of Hepatitis A pipeline products. The Hepatitis A pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEPATITIS A PIPELINE REPORT INCLUDES Panorama of Hepatitis A pipeline markets including statistics on therapeutic drugs and ...
August 2018
20 pages
Hepatitis C R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... from VPA Research with comprehensive information of Hepatitis C pipeline products. The Hepatitis C pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEPATITIS C PIPELINE REPORT INCLUDES Panorama of Hepatitis C pipeline markets including statistics on therapeutic drugs and ...
August 2018
340 pages
Hepatitis D R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... from VPA Research with comprehensive information of Hepatitis D pipeline products. The Hepatitis D pipeline guide presents complete overview of drugs ... and ready to use format. SCOPE OF HEPATITIS D PIPELINE REPORT INCLUDES Panorama of Hepatitis D pipeline markets including statistics on therapeutic drugs and ...
August 2018
50 pages
Hereditary Angioedema R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HEREDITARY ANGIOEDEMA PIPELINE REPORT INCLUDES Panorama of Hereditary Angioedema pipeline markets including statistics on therapeutic drugs and companies involved Hereditary Angioedema Pipeline candidates across various development ...
August 2018
70 pages
Herpes Labialis (Oral Herpes) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF HERPES LABIALIS (ORAL HERPES) PIPELINE REPORT INCLUDES Panorama of Herpes Labialis (Oral Herpes) pipeline markets including statistics on therapeutic drugs and companies involved Herpes Labialis (Oral Herpes) Pipeline candidates across ...
August 2018
30 pages
Herpes Zoster (Shingles) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HERPES ZOSTER (SHINGLES) PIPELINE REPORT INCLUDES Panorama of Herpes Zoster (Shingles) pipeline markets including statistics on therapeutic drugs and companies involved Herpes Zoster (Shingles) Pipeline candidates across various development ...
August 2018
40 pages
Heterozygous familial hypercholesterolemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PIPELINE REPORT INCLUDES Panorama of Heterozygous familial hypercholesterolemia pipeline markets including statistics on therapeutic drugs and companies involved Heterozygous familial hypercholesterolemia Pipeline candidates across various ...
August 2018
40 pages
Hidradenitis Suppurativa R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HIDRADENITIS SUPPURATIVA PIPELINE REPORT INCLUDES Panorama of Hidradenitis Suppurativa pipeline markets including statistics on therapeutic drugs and companies involved Hidradenitis Suppurativa Pipeline candidates across various development ...
August 2018
80 pages
Homozygous Familial Hypercholesterolemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... use format. SCOPE OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PIPELINE REPORT INCLUDES Panorama of Homozygous Familial Hypercholesterolemia pipeline markets including statistics on therapeutic drugs and companies involved Homozygous Familial Hypercholesterolemia Pipeline candidates across various development ...
August 2018
80 pages
Hospital Acquired Pneumonia (HAP) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF HOSPITAL ACQUIRED PNEUMONIA (HAP) PIPELINE REPORT INCLUDES Panorama of Hospital Acquired Pneumonia (HAP) pipeline markets including statistics on therapeutic drugs and companies involved Hospital Acquired Pneumonia (HAP) Pipeline candidates across ...
August 2018
120 pages
Hot Flashes R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HOT FLASHES PIPELINE REPORT INCLUDES Panorama of Hot Flashes pipeline markets including statistics on therapeutic drugs and companies involved Hot Flashes Pipeline candidates across various development ...
August 2018
50 pages
House Dust Mite Allergy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF HOUSE DUST MITE ALLERGY PIPELINE REPORT INCLUDES Panorama of House Dust Mite Allergy pipeline markets including statistics on therapeutic drugs and companies involved House Dust Mite Allergy Pipeline candidates across ...
August 2018
40 pages
Human Parainfluenza Virus 3 Infections R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF HUMAN PARAINFLUENZA VIRUS 3 INFECTIONS PIPELINE REPORT INCLUDES Panorama of Human Parainfluenza Virus 3 Infections pipeline markets including statistics on therapeutic drugs and companies involved Human Parainfluenza Virus 3 Infections Pipeline candidates across ...
August 2018
30 pages
Hyperalgesia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERALGESIA PIPELINE REPORT INCLUDES Panorama of Hyperalgesia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
30 pages
Hypercholesterolemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERCHOLESTEROLEMIA PIPELINE REPORT INCLUDES Panorama of Hypercholesterolemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
160 pages
Hypereosinophilic Syndrome R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HYPEREOSINOPHILIC SYNDROME PIPELINE REPORT INCLUDES Panorama of Hypereosinophilic Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Hypereosinophilic Syndrome Pipeline candidates across various development ...
August 2018
50 pages
Hyperglycemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERGLYCEMIA PIPELINE REPORT INCLUDES Panorama of Hyperglycemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
20 pages
Hyperinsulinemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERINSULINEMIA PIPELINE REPORT INCLUDES Panorama of Hyperinsulinemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Hyperlipidemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERLIPIDEMIA PIPELINE REPORT INCLUDES Panorama of Hyperlipidemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
170 pages
Hyperoxaluria R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPEROXALURIA PIPELINE REPORT INCLUDES Panorama of Hyperoxaluria pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Hyperphosphatemia In Chronic Kidney Disease R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... format. SCOPE OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PIPELINE REPORT INCLUDES Panorama of Hyperphosphatemia In Chronic Kidney Disease pipeline markets including statistics on therapeutic drugs and companies involved Hyperphosphatemia In Chronic Kidney Disease Pipeline candidates across ...
August 2018
40 pages
Hypertriglyceridemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERTRIGLYCERIDEMIA PIPELINE REPORT INCLUDES Panorama of Hypertriglyceridemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
90 pages
Hypertrophic Cardiomyopathy R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HYPERTROPHIC CARDIOMYOPATHY PIPELINE REPORT INCLUDES Panorama of Hypertrophic Cardiomyopathy pipeline markets including statistics on therapeutic drugs and companies involved Hypertrophic Cardiomyopathy Pipeline candidates across various development ...
August 2018
40 pages
Hyperuricemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPERURICEMIA PIPELINE REPORT INCLUDES Panorama of Hyperuricemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
50 pages
Hypoglycemia R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPOGLYCEMIA PIPELINE REPORT INCLUDES Panorama of Hypoglycemia pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
60 pages
Hypogonadotropic Hypogonadism (HH) R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HYPOGONADOTROPIC HYPOGONADISM (HH) PIPELINE REPORT INCLUDES Panorama of Hypogonadotropic Hypogonadism (HH) pipeline markets including statistics on therapeutic drugs and companies involved Hypogonadotropic Hypogonadism (HH) Pipeline candidates across various development ...
August 2018
50 pages
Hypoparathyroidism R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... is presented in user friendly and ready to use format. SCOPE OF HYPOPARATHYROIDISM PIPELINE REPORT INCLUDES Panorama of Hypoparathyroidism pipeline markets including statistics on therapeutic drugs and companies involved ...
August 2018
40 pages
Hypopharyngeal Cancer R&D Pipeline Analysis Report, H2-2018
US$ 2,200.00
... to use format. SCOPE OF HYPOPHARYNGEAL CANCER PIPELINE REPORT INCLUDES Panorama of Hypopharyngeal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Hypopharyngeal Cancer Pipeline candidates across various development ...
August 2018
110 pages
